-
'A scare': Brazil player leaps into tunnel in joy over goal
-
Britain's Amy Hunt wins European women's 100m gold
-
USA Swimming CFO Hilliard arrested for alleged theft
-
Trump order pushes for overhaul of childhood vaccine schedule
-
Trump insists Netanyahu relationship 'very good' despite Gaza rift
-
Global stocks mixed while oil prices jump on Hormuz
-
Ingebrigtsen delivers masterclass for seventh European athletics gold
-
Turkey MPs back historic law on reintegrating Kurdish militants
-
Colombia declares state of emergency after quake kills 111
-
'Dreams disappear' as Gaza students await evacuation to Italy
-
Golden relay double for Britain at Europeans as Marchand takes silver
-
Third European gold for Schilder in women's shot put
-
Barcelona's Araujo heads to Liverpool on loan
-
Golden relay double for Britain at Europeans as Marchand settles for silver
-
Tupac Shakur murder trial begins 30 years after rapper's death
-
US had hottest month on record in July
-
Russia bars only anti-war party from elections
-
Colombia quake leaves 69 dead, with more trapped under rubble
-
Boeing to divest tech ventures for stake in air-taxi startup
-
Bookmap Announces Partnership with Plus500 to Expand Futures Trading Access
-
Major quake rocks Colombia and neighbors, 18 confirmed dead
-
Barcelona turn down PSG offer for Torres
-
Brazil aircraft maker Embraer raises outlook after record revenue
-
Buildings collapse as major quake rocks Colombia and neighbors
-
Drought forces water restrictions across nearly 70 percent of France
-
Meta releases new AI model as Zuckerberg lays out vision
-
Europe wary as gas stocks languish at lows while winter looms
-
Freedom Holding Corp. Reports 40% Increase in Quarterly Revenue to $732.5 Million
-
OFunded Enters the Prop Trading Market With Broker-Backed Infrastructure From OFinancial Markets
-
What next for beleaguered FIFA president Infantino?
-
Stocks mostly flat with focus on US inflation
-
Greece contains new wind-driven fire near Athens
-
UK radio broke rules in announcing king's death: watchdog
-
Massive shake-up of Hungary media after Orban's exit
-
Europe braces for another summer heatwave
-
Days of heavy rain leave at least 16 dead in Philippines
-
Tentoglou keep bid for fourth Euro title on course, Nowicki misses out
-
Bezos consortium nears deal to buy Liverpool stake: report
-
MEXC Sponsors Yohani's Colombo Concert, Bridging Sri Lankan Culture and Global Digital Finance
-
Stocks mostly rise with focus on US inflation
-
Parts of Germany's Rhine could become unnavigable, group warns
-
Days of heavy rain leave at least 13 dead in Philippines
-
Base Markets Appoints Nazim Moussaoui as Head of Premium Clients and Partnerships
-
Ex-Thai MP shoots dead local official over money row
-
US, South Korea to drill for new threats from North
-
July was Spain's hottest month on record: weather agency
-
SCANDIC TRADE Ultimate 2.6 är färdigutvecklat – SNC SCANDIC ECO-Systemet är nu komplett
-
SCANDIC TRADE Ultimate 2.6 jest gotowy – system SNC SCANDIC ECO jest kompletny
-
SCANDIC TRADE Ultimate 2.6 je hotový – systém SNC SCANDIC ECO je kompletní
-
تم الانتهاء من تطوير SCANDIC TRADE Ultimate 2.6 – وبذلك أصبح نظام SNC SCANDIC ECO متكاملاً
Texas judge to decide fate of abortion pill in US
A conservative Texas judge is poised to rule on whether to impose a nationwide ban on a drug used for more than half of the abortions in the United States.
Mifepristone, also known as RU-486, is one component of a two-drug regimen used for medication abortion and has been on the US market for more than 20 years.
Anti-abortion groups, galvanized by the Supreme Court's ruling in June overturning the constitutional right to an abortion, have now set their sights on obtaining a ban on the abortion pill.
In a lawsuit filed in November with a Texas judge appointed by former Republican president Donald Trump, an alliance of anti-abortion groups claims the US Food and Drug Administration (FDA) should never have approved the "dangerous" drug.
"The FDA failed America's women and girls when it chose politics over science and approved chemical abortion drugs for use in the United States," they said.
Attorneys for the Alliance Defending Freedom, a Christian legal advocacy group, asked the judge to impose an immediate injunction withdrawing mifepristone from the list of FDA-approved drugs.
The FDA urged the judge to reject the request.
"The public interest would be dramatically harmed by effectively withdrawing from the marketplace a safe and effective drug that has lawfully been on the market for 22 years," it said.
US District Court Judge Matthew Kacsmaryk has given the parties until February 24 to file briefs in the case and is expected to rule sometime after that.
Around 15 US states have imposed restrictions on abortion since the Supreme Court ruling and banned sales of the abortion pill.
Groups defending access to abortion have expressed concern that Kacsmaryk, who previously worked for the conservative First Liberty Institute, could impose a nationwide ban on its sale.
"Access to medication abortion would end across the country -- even in those states where abortion rights are protected," the Center for Reproductive Rights said.
The American Civil Liberties Union said if the suit is successful, it could "force millions of Americans seeking abortions to undergo operations (and) carry unwanted pregnancies to term."
Mifepristone is used in combination with another drug called misoprostol and is approved for use in the United States up to 10 weeks of pregnancy.
Medication abortions account for 54 percent of all abortions in the United States, according to the Guttmacher Institute, a reproductive health policy and research group.
J.AbuHassan--SF-PST